Therefore, hypercalcemia malignancy suspicion was intensified by identifying parathormone (PTH) suppression, in addition to light-chain screening with a positive monoclonal gammopathy and a bone biopsy with 60% of clonal plasma cells receiving a diagnosis of multiple myeloma with an ominous outcome. This evidence concerns the gene PTH and Hypercalcemia.